Editorial
Adverse Drug Reactions
Abstract
Physicians are confronted daily with new information about new drugs, old drugs, using these agents in different ways, at different doses and comprehending the safety profiles with all of these medications. These medications may be completely new drug entities, structurally diverse compounds, new formulations of older drugs and even "me-too" drugs which are of the same chemical class and possess the same pharmacologic profile as previously approved medications, although they have slight structural alterations. This "drug-use process" is truly dynamic and health care providers are mandated to be proficient in their knowledge of these drugs, as they relate to their scope of practice.1This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.